首页> 外文期刊>Hepatitis Monthly >Evaluation of microRNA Gene Polymorphisms in Liver Transplant Patients with Hepatocellular Carcinoma
【24h】

Evaluation of microRNA Gene Polymorphisms in Liver Transplant Patients with Hepatocellular Carcinoma

机译:肝脏移植患者肝细胞癌患者的微小RONA基因多态性评价

获取原文

摘要

Background: Genetic polymorphism in the miRNA sequence might alter miRNA expression and/or maturation, which is associated with the development and progression of hepatocellular carcinoma (HCC) in liver transplant patients. Objectives: Therefore, the prevalence of miRNA-146a G C (rs2910164), miRNA-499A G (rs3746444), miRNA-149C T (rs2292832), and miRNA-196a-2 C T (rs11614913) gene polymorphisms was evaluated in liver recipients with HCC with or without experiencing graft rejection. Methods: In a cross-sectional study, tissue samples were collected from 60 HCC patients who underwent liver transplant surgery at Namazi Hospital, Shiraz, Iran, in 2013 - 2015. A control group consisting of 120 individuals was randomly selected, as well. The genomic DNA was extracted from collected tissues and blood samples. The miRNA-146a (rs2910164), miRNA-499 (rs3746444), miRNA-149 (rs2292832), and miRNA-196a-2 (rs11614913) gene polymorphisms were evaluated in patients with HCC using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Results: The CC genotype and C allele of the miRNA-146a (rs2910164) polymorphism were significantly associated with the increased risk of transplant rejection in patients with HCC (P = 0.05 and P = 0.05, respectively). The CC genotype and C allele of the miRNA-146a (rs2910164) were also significantly more frequent in male liver transplant patients who experienced acute rejection than in non-rejected ones (P = 0.05 and P = 0.03, respectively). However, no significant association was found between the genotypes and alleles of miRNA-499 (rs3746444), miRNA-149 (rs2292832), and miRNA-196a-2 (rs11614913) polymorphisms and HCC outcomes in liver transplant recipients. Conclusions: The importance of the CC genotype and C allele of the miRNA-146a (rs2910164) polymorphism in increasing the risk of transplant rejection was confirmed, but it needs further studies in larger populations.
机译:背景:miRNA序列中的遗传多态性可能会改变miRNA表达和/或成熟,这与肝移植患者中肝细胞癌(HCC)的显影和进展相关。发明目标:MiRNA-146A G> C(RS2910164),miRNA-499A> G(RS3746444),miRNA-149C> T(RS2292832)和miRNA-196A-2 C> T(RS11614913)基因多态性的患病率是在肝脏受体中评估,具有或不经历移植物抑制。方法:在横截面研究中,从2013年至2015年在伊朗南纳齐医院接受肝脏移植手术的60名HCC患者中收集组织样品。随机选择了由120个个体组成的对照组。从收集的组织和血液样品中提取基因组DNA。使用聚合酶链反应限制片段长度多态性,在HCC患者中评估MiRNA-146a(RS2910164),miRNA-499(RS2292832),miRNA-149(RS2292832)和MiRNA-196A-2(RS11614913)基因多态性( PCR-RFLP)方法。结果:MiRNA-146A(RS2910164)多态性的CC基因型和C等位基因与HCC患者移植抑制的风险增加显着相关(分别分别为P = 0.05和P = 0.05)。 MiRNA-146a(RS2910164)的CC基因型和C等位基因在经历急性排斥的男性肝脏移植患者中的显着更频繁地比在非拒绝的患者中(P = 0.05和P = 0.03)。然而,在miRNA-499(RS3746444),miRNA-149(RS2292832)和miRNA-196A-2(RS11614913)的多态性和HCC结果之间没有发现显着的关联在肝脏移植受者中的基因型和等位基因之间。结论:确认了MiRNA-146A的CC基因型和C等位基因的重要性提高移植排斥风险的多态性,但它需要进一步的群体研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号